Toxoplasma chorioretinitis
ICD-10 B57.2 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals and during pregnancy. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. The infection is often acquired through ingestion of oocysts found in contaminated food or water, or through contact with infected cat feces. In immunocompetent individuals, Toxoplasma chorioretinitis may remain asymptomatic or present with mild symptoms, but in those with weakened immune systems, such as HIV/AIDS patients, it can lead to severe ocular complications. Diagnosis typically involves clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography or OCT (optical coherence tomography). Treatment usually includes antiparasitic medications such as pyrimethamine and sulfadiazine, often combined with corticosteroids to reduce inflammation. Early diagnosis and treatment are crucial to prevent irreversible damage to the retina and preserve vision.
Detailed ocular examination findings, imaging results, and treatment plans.
Patients presenting with vision changes, floaters, or diagnosed with Toxoplasma infection.
Documentation must clearly indicate the extent of retinal and choroidal involvement.
Comprehensive history of exposure, serological test results, and treatment response.
Immunocompromised patients with systemic Toxoplasma infection presenting with ocular symptoms.
Need for interdisciplinary communication regarding patient management and follow-up.
Used for initial evaluation of a patient presenting with symptoms of chorioretinitis.
Complete ocular examination findings and patient history.
Ophthalmologists should document all relevant findings to support the diagnosis.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience eye pain or redness.
Diagnosis is typically made through clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography.
Treatment usually involves antiparasitic medications such as pyrimethamine and sulfadiazine, often combined with corticosteroids to reduce inflammation.
